• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用简单的血液学和生化学指标对 COVID-19 进行早期的鉴别诊断和前瞻性分级。

Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables.

机构信息

Department of Laboratory Medicine, Renmin Hospital of Wuhan University, Wuhan, 430060, China.

Department of Laboratory Medicine, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China; Guangdong Provincial Key Laboratory of Research on Emergency in TCM, the Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510120, China.

出版信息

Diagn Microbiol Infect Dis. 2021 Feb;99(2):115169. doi: 10.1016/j.diagmicrobio.2020.115169. Epub 2020 Oct 21.

DOI:10.1016/j.diagmicrobio.2020.115169
PMID:33202303
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7577249/
Abstract

We evaluated simple laboratory variables to discriminate COVID-19 from bacterial pneumonia or influenza and for the prospective grading of COVID-19. Multivariate logistic regression and receiver operating characteristic curve were used to estimate the diagnostic performance of the significant discriminating variables. A comparative analysis was performed with different severity. The leukocytosis (P = 0.017) and eosinopenia (P = 0.001) were discriminating variables between COVID-19 and bacterial pneumonia with area under the curve (AUC) of 0.778 and 0.825. Monocytosis (P = 0.003), the decreased lymphocyte-to-monocyte ratio (P < 0.001), and the increased neutrophil-to-lymphocyte ratio (NLR) (P = 0.028) were predictive of influenza with AUC of 0.723, 0.895, and 0.783, respectively. Serum amyloid protein, lactate dehydrogenase, CD3 cells, and the fibrinogen degradation products had a good correlation with the severity of COVID-19 graded by age (≥50) and NLR (≥3.13). Simple laboratory variables are helpful for rapid diagnosis on admission and hierarchical management of COVID-19 patients.

摘要

我们评估了简单的实验室变量,以区分 COVID-19 与细菌性肺炎或流感,并对 COVID-19 进行前瞻性分级。使用多元逻辑回归和接收者操作特征曲线来估计有意义的鉴别变量的诊断性能。进行了不同严重程度的比较分析。白细胞增多症(P=0.017)和嗜酸性粒细胞减少症(P=0.001)是 COVID-19 与细菌性肺炎之间的鉴别变量,曲线下面积(AUC)分别为 0.778 和 0.825。单核细胞增多症(P=0.003)、淋巴细胞与单核细胞比值降低(P<0.001)和中性粒细胞与淋巴细胞比值升高(NLR)(P=0.028)是流感的预测指标,AUC 分别为 0.723、0.895 和 0.783。血清淀粉样蛋白、乳酸脱氢酶、CD3 细胞和纤维蛋白原降解产物与年龄(≥50 岁)和 NLR(≥3.13)分级的 COVID-19 严重程度具有良好的相关性。简单的实验室变量有助于在入院时快速诊断和对 COVID-19 患者进行分层管理。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ba/7577249/05aae1435264/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ba/7577249/b012ac53d174/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ba/7577249/05aae1435264/gr2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ba/7577249/b012ac53d174/gr1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e8ba/7577249/05aae1435264/gr2_lrg.jpg

相似文献

1
Differential diagnosis and prospective grading of COVID-19 at the early stage with simple hematological and biochemical variables.运用简单的血液学和生化学指标对 COVID-19 进行早期的鉴别诊断和前瞻性分级。
Diagn Microbiol Infect Dis. 2021 Feb;99(2):115169. doi: 10.1016/j.diagmicrobio.2020.115169. Epub 2020 Oct 21.
2
Monocyte absolute count as a preliminary tool to distinguish between SARS-CoV-2 and influenza A/B infections in patients requiring hospitalization.单核细胞绝对计数作为区分需要住院治疗的患者感染新冠病毒和甲型/乙型流感的初步工具。
Infez Med. 2020 Dec 1;28(4):534-538.
3
Neutrophil-to-lymphocyte ratio, a critical predictor for assessment of disease severity in patients with COVID-19.中性粒细胞与淋巴细胞比值,新冠肺炎患者疾病严重程度评估的关键预测指标。
Int J Lab Hematol. 2021 Apr;43(2):329-335. doi: 10.1111/ijlh.13374. Epub 2020 Oct 25.
4
Diagnostic value of peripheral hematologic markers for coronavirus disease 2019 (COVID-19): A multicenter, cross-sectional study.外周血标志物对 2019 年冠状病毒病(COVID-19)的诊断价值:一项多中心、横断面研究。
J Clin Lab Anal. 2020 Oct;34(10):e23475. doi: 10.1002/jcla.23475. Epub 2020 Jul 17.
5
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.中性粒细胞与淋巴细胞比值可预测 2019 冠状病毒病重症患者的早期病情。
J Transl Med. 2020 May 20;18(1):206. doi: 10.1186/s12967-020-02374-0.
6
Distinguishing between COVID-19 and influenza during the early stages by measurement of peripheral blood parameters.通过测量外周血参数在早期区分 COVID-19 和流感。
J Med Virol. 2021 Feb;93(2):1029-1037. doi: 10.1002/jmv.26384. Epub 2020 Aug 13.
7
The value of clinical parameters in predicting the severity of COVID-19.临床参数在预测 COVID-19 严重程度中的价值。
J Med Virol. 2020 Oct;92(10):2188-2192. doi: 10.1002/jmv.26031. Epub 2020 Jun 2.
8
The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China.新冠肺炎患者中性粒细胞与淋巴细胞比值和 D-二聚体的临床意义:中国苏州的一项回顾性研究。
Thromb Res. 2020 Aug;192:3-8. doi: 10.1016/j.thromres.2020.05.006. Epub 2020 May 6.
9
Prognostic implications of neutrophil-lymphocyte ratio in COVID-19.中性粒细胞与淋巴细胞比值对 COVID-19 的预后意义。
Eur J Clin Invest. 2021 Jan;51(1):e13404. doi: 10.1111/eci.13404. Epub 2020 Sep 25.
10
Factors Associated with a Positive Severe Acute Respiratory Syndrome Coronavirus 2 Testing in Suspected Cases Presenting with Pneumonia: A Retrospective Cohort Study in a Single Medical Center.与疑似肺炎患者 SARS-CoV-2 检测呈阳性相关的因素:单中心回顾性队列研究。
Respiration. 2020;99(9):739-747. doi: 10.1159/000508398. Epub 2020 Nov 18.

引用本文的文献

1
Can Haematological Parameters Discriminate COVID-19 from Influenza?血液学参数能否区分新冠病毒感染和流感?
J Clin Med. 2023 Dec 28;13(1):186. doi: 10.3390/jcm13010186.
2
Hematological Parameters and Procalcitonin as Discriminants between Bacterial Pneumonia-Induced Sepsis and Viral Sepsis Secondary to COVID-19: A Retrospective Single-Center Analysis.血液学参数和降钙素原鉴别 COVID-19 相关病毒性肺炎继发细菌性肺炎合并脓毒症:一项回顾性单中心分析。
Int J Mol Sci. 2023 Mar 7;24(6):5146. doi: 10.3390/ijms24065146.
3
Hematological- and Immunological-Related Biomarkers to Characterize Patients with COVID-19 from Other Viral Respiratory Diseases.
用于区分新型冠状病毒肺炎患者与其他病毒性呼吸道疾病患者的血液学和免疫学相关生物标志物
J Clin Med. 2022 Jun 21;11(13):3578. doi: 10.3390/jcm11133578.
4
Elevated plasma level of the glycolysis byproduct methylglyoxal on admission is an independent biomarker of mortality in ICU COVID-19 patients.入院时血液中糖酵解副产物甲基乙二醛水平升高是 ICU COVID-19 患者死亡的独立生物标志物。
Sci Rep. 2022 Jun 9;12(1):9510. doi: 10.1038/s41598-022-12751-y.
5
Usefulness of laboratory parameters and chest CT in the early diagnosis of COVID-19.实验室参数和胸部 CT 在 COVID-19 早期诊断中的作用。
Rev Inst Med Trop Sao Paulo. 2022 Apr 4;64:e28. doi: 10.1590/S1678-9946202264028. eCollection 2022.
6
Ruling Out Coronavirus Disease 2019 in Patients with Pneumonia: The Role of Blood Cell Count and Lung Ultrasound.排除肺炎患者的新型冠状病毒肺炎:血细胞计数和肺部超声的作用
J Clin Med. 2021 Aug 6;10(16):3481. doi: 10.3390/jcm10163481.
7
Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leukocytes sequencing data set of patients with COVID-19.基于 COVID-19 患者血液白细胞测序数据集的 SARS-CoV-2 感染相关基因的全基因组筛选。
J Med Virol. 2021 Sep;93(9):5544-5554. doi: 10.1002/jmv.27093. Epub 2021 May 28.
8
Do Blood Eosinophils Predict in-Hospital Mortality or Severity of Disease in SARS-CoV-2 Infection? A Retrospective Multicenter Study.血液嗜酸性粒细胞能否预测新型冠状病毒肺炎感染的院内死亡率或疾病严重程度?一项回顾性多中心研究。
Microorganisms. 2021 Feb 8;9(2):334. doi: 10.3390/microorganisms9020334.